CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Mechanism of Action

CJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.

Typical Dosage (Research)

CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.

Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.

Side Effects & Risks

Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.

May affect blood glucose levels. Long-term effects on pituitary function not fully understood.

Who Uses CJC-1295

Those seeking anti-aging benefits, improved body composition, enhanced recovery, and better sleep.